BioCentury
ARTICLE | Distillery Therapeutics

Cancer

August 23, 2018 3:53 PM UTC

Cell culture and mouse studies suggest inhibiting IRE1 or its RNase activity could help treat triple-negative breast cancer (TNBC). In a panel of human breast cancer cell lines, levels of IRE1 RNase a...